CLINICAL_TRIALS
trial_result
· 2023-03-23
Clinical Trial Update: Phase II Eltrombopag in Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Summary
Phase II trial update of eltrombopag in chronic lymphocytic leukemia has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: CLL, Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-03-23